FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
Immunocompromised patients can still receive convalescent plasma
Dynamically Updating Models Can Improve Prediction of COVID-19 Survival
Drift in model calibration performance was detected immediately, with minor fluctuations in discrimination
Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization
Posthospitalization prevalence of residual lung abnormalities estimated at 11.7 percent in sensitivity analyses
FDA Moves to Ease Restrictions on Gay Men Giving Blood
Administration says it expects to issue updated draft guidance in the coming months
Temporal Improvement Seen in Standard of Care for Hospitalized COVID-19 Patients
Outcomes improved from Adaptive COVID-19 Treatment Trial-2 to ACTT-3, although potential explanatory factors were similar
Demographic Disparities Seen in Firearm Fatality Rates
Maximum rates of firearm homicides higher among non-Hispanic Black and Hispanic versus White men
Medical Masks Similar to N95 Respirators for Preventing COVID-19
No significant difference seen with medical masks versus N95 respirators for health care personnel providing care to COVID-19 patients
Studies Compare Various Treatments for COVID-19
Sotrovimab effective compared with molnupiravir; second study shows no effect for angiotensin receptor blockers in terms of illness severity
New COVID-19 Variant XBB Gaining Ground Among Americans
New omicron subvariant is taking hold in the United States, health officials say, though it does not look more severe than its predecessors
Clinical Report Addresses Need for POCUS Guidelines for NICU
Hospital-wide POCUS committee should be established, have oversight responsibilities for implementation and QA of POCUS program
